MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21873/anticanres.15393

Медицинская библиотека · Anticancer research · 2021

Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma.

Yumioka Tetsuya, Honda Masashi, Shimizu Ryutaro, Teraoka Shogo, Yamaguchi Noriya, Kawamoto Bunya, Iwamoto Hideto, Morizane Shuichi, Hikita Katsuya, Takenaka Atsushi

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

This study aimed to investigate the response to platinum-based chemotherapy rechallenge in patients with pembrolizumab-refractory urothelial carcinoma.

PATIENTS AND

METHODS

We retrospectively reviewed 14 patients with pembrolizumab-refractory urothelial carcinoma. Each patient received a regimen that they had not previously received (paclitaxel plus carboplatin in 10, gemcitabine plus docetaxel and carboplatin in four). Tumor response and adverse events were assessed. We evaluated overall survival from the chemotherapy rechallenge start date until death.

RESULTS

The median overall survival was 11.2 months. The disease-control rate was 85.7%. Partial responses occurred in the metastases in lymph nodes in three (37.5%) patients, lung in one (25%), peritoneal in three (75%), and liver in three (100%). Neutropenia of grade ≥3 occurred in 13 (92.9%) patients.

CONCLUSION

The activity of platinum-based chemotherapy rechallenge after pembrolizumab was maintained. Neutropenia was observed in most patients.

Для цитирования: Yumioka Tetsuya, Honda Masashi, Shimizu Ryutaro, Teraoka Shogo, Yamaguchi Noriya, Kawamoto Bunya, Iwamoto Hideto, Morizane Shuichi, Hikita Katsuya, Takenaka Atsushi. Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma.. Anticancer research. 2021. DOI: 10.21873/anticanres.15393.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.